Bifogade filer
DOWNLOAD THE PRESS RELEASE
Kurs
+0,77%
Kalender
| Est. tid* | ||
| 2025-07-28 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-07 | - | X-dag ordinarie utdelning EL 3.95 EUR |
| 2025-04-30 | - | Extra Bolagsstämma |
| 2025-04-30 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-07-25 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-03 | - | X-dag ordinarie utdelning EL 3.95 EUR |
| 2024-04-30 | - | Extra Bolagsstämma |
| 2024-04-30 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-07-26 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-22 | - | X-dag ordinarie utdelning EL 3.23 EUR |
| 2023-05-17 | - | Extra Bolagsstämma |
| 2023-05-17 | - | Årsstämma |
| 2023-03-10 | - | Bokslutskommuniké 2022 |
| 2022-07-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-30 | - | X-dag ordinarie utdelning EL 2.51 EUR |
| 2022-05-25 | - | Extra Bolagsstämma |
| 2022-05-25 | - | Årsstämma |
| 2022-03-11 | - | Bokslutskommuniké 2021 |
| 2021-07-30 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | X-dag halvårsutdelning EL 1.08 |
| 2021-05-21 | - | Årsstämma |
| 2021-05-21 | - | Extra Bolagsstämma |
| 2021-03-12 | - | Bokslutskommuniké 2020 |
| 2020-12-23 | - | X-dag bonusutdelning EL 1.15 |
| 2020-06-25 | - | Årsstämma |
| 2020-06-25 | - | Extra Bolagsstämma |
| 2019-10-30 | - | Kvartalsrapport 2019-Q3 |
EssilorLuxottica completes acquisition of Optegra
Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition of Optegra from MidEuropa.
Under the Optegra, Lexum and Iris brands, Optegra is a fast-growing and highly integrated ophthalmology platform operating an extensive network of over 70 eye hospitals and diagnostic facilities in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands.
A natural fit for EssilorLuxottica’s expanding med-tech portfolio, this acquisition represents a significant milestone in the Group’s strategy to enhance eye-health solutions and improve access to the most personalized and seamless patient journey.
The transaction has been cleared by all relevant competition authorities.